Kathleen London-Lopes
Advanced Practice Midwife · Fall River, MANPI 1841455698
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Among advanced practice midwife clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $21.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$382
- Astellas Pharma US Inc$257
- Mayne Pharma Commercial LLC$143
- Mylan Pharmaceuticals Inc.$136
- Agile Therapeutics, Inc.$111
- Exeltis, USA Inc.$96
- plus $473 from 12 others
What the payments were for
- Food & beverage$1,50094%
- Education$1006%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $382 |
| Astellas Pharma US Inc | 4 | $257 |
| Mayne Pharma Commercial LLC | 6 | $143 |
| Mylan Pharmaceuticals Inc. | 7 | $136 |
| Agile Therapeutics, Inc. | 5 | $111 |
| Exeltis, USA Inc. | 6 | $96 |
| Sumitomo Pharma America, Inc. | 5 | $96 |
| Idorsia Pharmaceuticals US Inc | 5 | $91 |
| Myovant Sciences Inc. | 4 | $67 |
| Therapeuticsmd, Inc. | 2 | $41 |
| Merck | 2 | $35 |
| Medicem Inc. | 2 | $29 |
| Avion Pharmaceuticals | 2 | $26 |
| Novo Nordisk | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Sage Therapeutics, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$122
How this compares
$1,600 in reported general payments places this provider in the 95th percentile of 159 advanced practice midwife providers in Massachusetts.
See all advanced practice midwife providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 35 | $1,911 |
| ValacyclovirValacyclovir Hcl | 18 | $547 |
| ProgesteroneProgesterone, Micronized | 13 | $363 |
Paid to pharmacies, not to this prescriber.
Other advanced practice midwife in Fall River
- Julie McDonaldFall River$5K
- Phyllis CorreiaFall River$3K
- Evelyn ReshPittsfield$26K
- Jo Anna RorieBoston$11K
- Emily Swisher-RosaBoston$8K
- Lara SimondiBoston$3K
- Nancy DavidsonBoston$1K
- Sherriann PerivolotisConcord$1K
- Lorna McCarthyFramingham$961
- Amanda MolterLeominster$885
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.